John Lynch, DO
Radiation Oncology · Jonesboro, ARNPI 1659320083
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 40 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 15.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $232 and has fallen 77.8% since, to $51 in 2025. That places this record below the midpoint for radiation oncology clinicians in AR, where the typical reported total is $819.
Across 40 payments — averaging $19.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$120
- Progenics Pharmaceuticals, Inc.$117
- Pharmacyclics LLC, An Abbvie Company$79
- Merck$68
- Johnson & Johnson$45
- Stemline Therapeutics Inc.$43
- plus $315 from 15 others
What the payments were for
- Food & beverage$786100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 7 | $120 |
| Progenics Pharmaceuticals, Inc. | 1 | $117 |
| Pharmacyclics LLC, An Abbvie Company | 4 | $79 |
| Merck | 4 | $68 |
| Johnson & Johnson(2 entities) | 3 | $45 |
| Stemline Therapeutics Inc. | 2 | $43 |
| Blue Earth Diagnostics | 2 | $39 |
| Bayer | 2 | $36 |
| Daiichi Sankyo Inc. | 2 | $34 |
| Angiodynamics, Inc. | 1 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $25 |
| Teleflex LLC | 1 | $23 |
| Myovant Sciences Inc. | 1 | $20 |
| Gilead | 1 | $17 |
| G1 Therapeutics, Inc. | 1 | $15 |
| Lilly USA, LLC | 1 | $14 |
| Boston Scientific | 1 | $14 |
| GSK | 1 | $14 |
| CTI Biopharma Corp. | 1 | $13 |
| Puma Biotechnology, Inc. | 1 | $12 |
| AMAG Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PYLARIFY$117
How this compares
$786 in reported general payments places this provider in the 45th percentile of 45 radiation oncology providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 71 | $577 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Jonesboro
- Hiba AhmedJonesboro$782
- John AllgoodJonesboro$260
- Christian OkoyeJonesboro$235
- Mahbuba MeemJonesboro$145
- Brooke WillowsJonesboro$0
- Foster LasleyFayetteville$8K
- Matthew McKeeverFort Smith$5K
- Fen XiaLittle Rock$4K
- Chris McClintonFayetteville$4K
- Mausam PatelLittle Rock$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.